从China供应商批量进口Abt-737

ABT-737 is a BCL-2 inhibitor compound supplied by Xi¡an Chemsoar Medical Technology Co Ltd, offered in a 10g quantity with a purity exceeding 98.0%. The product targets BCL-2 family proteins, a key mechanism in apoptosis regulation, making it a critical reagent for cancer research and drug development workflows. Its high purity minimises interference in assays, ensuring reproducible results in cell-based and biochemical studies.

The compound is standard for in vitro applications, with typical solubility in DMSO or ethanol at concentrations up to 10 mM for stock solutions. Industry practice often pairs ABT-737 with complementary inhibitors to study synergistic effects in apoptosis pathways. As a small-molecule inhibitor, it is commonly used in preclinical research to validate BCL-2 dependency in tumour models, with typical storage conditions at -20°C under desiccation to maintain stability.

Pharmaceutical and biotechnology laboratories source ABT-737 for target validation, high-throughput screening and mechanistic studies. Buyers confirm trade terms directly with Xi¡an Chemsoar, as the listing does not specify MOQ, Incoterms or certification status beyond the stated purity. The product is packaged for laboratory use, with handling aligned to standard chemical safety protocols for bioactive compounds.

Xi¡an Chemsoar Medical Technology Co Ltd operates from Room 704, No.8 Huacheng International on Changan South Road in Xi’an, Shaanxi Province. The supplier is classified as an imported-tier provider with a harbor trust tier, indicating a baseline verification level for international trade. The company’s profile does not state active response metrics, with a current response rate of 0.00% and no recorded average response hours.

The listing describes the supplier as a provider of pharmaceutical and biotechnology chemicals, with ABT-737 as one of its research-grade compounds. No additional details are provided about the company’s size, history, certifications beyond the product’s stated purity, or client base. Buyers should verify operational capacity and quality systems directly with the supplier, as these are not confirmed in the available data.